HCID 69060862, compound → HCID 178424556, compound
Reaction equation
C([N:5]1[C:9]([NH:10][C:11]([C:13]2[CH:28]=[CH:27][C:16]3[N:17]([C:20]4[CH:25]=[CH:24][CH:23]=[C:22]([F:26])[CH:21]=4)[CH:18]=[N:19][C:15]=3[CH:14]=2)=[O:12])=[CH:8][C:7]([C:29]2[CH:30]=[C:31]([CH3:35])[CH:32]=[CH:33][CH:34]=2)=[N:6]1)(C)(C)C>C(O)=O>[C:31]1([CH3:35])[CH:32]=[CH:33][CH:34]=[C:29]([C:7]2[CH:8]=[C:9]([NH:10][C:11]([C:13]3[CH:28]=[CH:27][C:16]4[N:17]([C:20]5[CH:25]=[CH:24][CH:23]=[C:22]([F:26])[CH:21]=5)[CH:18]=[N:19][C:15]=4[CH:14]=3)=[O:12])[NH:5][N:6]=2)[CH:30]=1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
General procedure for t-butyl cleavage: N-(2-tert-butyl-5-m-tolyl-2H-pyrazol-3-yl) 1-(3-Fluoro-phenyl)-1H-benzimidazole-5-carboxamide (110 mg, 0.235 mmol) was dissolved in formic acid (3 mL) and the mixture stirred at reflux for 30 min. The solvent was then evaporated and chased with CHCl3 and Et2O and the residue triturated with MeOH. The resulting precipitate was filtered off and washed with MeOH and CHCl3 to give N-(5-m-tolyl-2H-pyrazol-3-yl) 1-(3-fluorophenyl)-1H-benzimidazole-5-carboxamide: 1H NMR (400 MHz, CDCl3) δ 2.55 (s, 3H), 7.05 (br.s, 1H), 7.18 (br.d, J=8.4 Hz, 1H), 7.33-7.43 (m, 2H), 7.57 (br.d, J=7.6 Hz, 1H), 7.62 (br.d, J=8.0 Hz, 2H), 7.70-7.74 (m, 2H), 7.78 (d, J=8.4 Hz, 1H), 8.07 (dd, J=8.0 Hz, J=2.0 Hz, 1H), 8.54 (s, 1H), 8.75 (s, 1H); MS (ES+): m/z 412 [MH+].
Workup
- temperatureat reflux for 30 min
- customThe solvent was then evaporated
- customthe residue triturated with MeOH
- filtrationThe resulting precipitate was filtered off
- washwashed with MeOH and CHCl3
Sources & evidence
- ORD record
- ord-5568cec7b8aa48ddaac7e1015f023f1d
- Source dataset
- uspto-grants-2009_02
- Patent number
- US07485658B2
Reaction notes
Loading…